Study to help people stick with their PrEP
Part of Immune system & allergy, Infections clinical trials.
This study tests ways to help people stick with their PrEP (the medicine that prevents HIV). If you're getting PrEP through West Virginia Health Right and have a smartphone, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are starting or already taking PrEP (medicine to prevent HIV) — either as pills or shots — prescribed by a doctor at West Virginia Health Right.
- Your PrEP is filled at the West Virginia Health Right pharmacy.
- You have a smartphone you can use for the study.
- You are not getting your PrEP care from another clinic outside West Virginia Health Right.
- You have not tested positive for HIV.
- You are not taking a short course of oral PrEP right before switching to the injectable PrEP.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether phone-based (iPhone/Android) text-message support can improve how consistently people use PrEP, an HIV prevention medicine. It may help you stay on track with refills and clinic visits, especially if you’re at higher risk of stopping PrEP.
This study tests a smartphone-based program to help people who use drugs (opioids or stimulants) stay engaged with HIV prevention tools like PrEP. If you are already eligible for PrEP but haven't been using prevention services consistently, this app may help you stay on track.
This study looks at whether people already taking PrEP (a daily pill to prevent HIV) can share HIV self-test kits and PrEP information with friends or others in their social network. It may help you if you are on PrEP and want to help others learn about HIV prevention.
This study tests a tool to help Black women decide if PrEP (a daily pill to prevent HIV) is right for them. It may help you learn more about HIV prevention options.
This study tests a new approach to help men at risk for HIV stay healthy by providing access to PrEP through a mobile app. The goal is to see if the program helps men start and stay on PrEP compared to standard care.
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.